Precision Diagnostics
Clinical Intelligence Hub • Expert Curation
Precision diagnostic profiling translates to proactive disease screening and biological age optimization. Our clinical board reviews advanced epigenetic clocks (like OMICm Age, Symphony Organ Age, and Dunedin Pace) and circulating tumor DNA (ctDNA) liquid biopsies. Early detection allows you to manage systemic aging risks years before they manifest.
Discover how MRI biological age tracking uses 3D deep learning to analyze multi-organ aging patterns, offering a powerful structural view of personal health.
A new clinical trial evaluates the Nous-209 Lynch syndrome cancer vaccine, demonstrating powerful immune activation and key steps toward cancer interception.
The InferAging biological age clock uses non-invasive behavioral markers to detect systemic decline and bypass traditional chronological age errors.
Discover how a new non-invasive aging clock tracks biological age deviations to reveal hidden risks like gut barrier dysfunction and chronic inflammation.
Discover how predictive multi-omic screening and OmicFormer utilize statistical priors to solve generalization challenges in disease risk prediction models.
A new AI framework, OmicFormer, utilizes statistical priors to improve the accuracy of omics disease prediction across diverse clinical patient cohorts.
A groundbreaking analysis reveals why common markers fail to show causation, redefining the limits of biological age rejuvenation in modern longevity science.
Are new RNA biological age testing tools like the Pasta clock safe and effective? Discover what transcriptomic clocks reveal about cellular health.
This lung cancer blood test study shows how tracking methylated ctDNA at diagnosis can predict survival rates and guide proactive clinical decisions.